SeaCrest Wealth Management’s Core Laboratories CLB Stock Holding History

SeaCrest Wealth Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-233	Closed	-$16K	–	749
2019 Q1	$16K	Buy	233 +19	+9%	+$1.27K	﹤0.01%	1367
2018 Q4	$13K	Sell	214 -121	-36%	-$10.4K	﹤0.01%	1398
2018 Q3	$39K	Sell	335 -83	-20%	-$9.36K	0.01%	1099
2018 Q2	$53K	Buy	418 +94	+29%	+$11.4K	0.01%	958
2018 Q1	$35K	Buy	324 +126	+64%	+$13.9K	0.01%	1096
2017 Q4	$22K	Buy	+198	New	+$19.8K	﹤0.01%	1302

Other funds holding CLB

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

SeaCrest Wealth Management's CLB Position: Q2 2019 in Review

SeaCrest Wealth Management sold out of Core Laboratories (CLB) in Q2 2019, closing a stake of 233 shares — an estimated $16K sold.

SeaCrest Wealth Management first reported a position in CLB in Q4 2017 and held it in 6 quarters. The position peaked at $53K in Q2 2018. 304 funds tracked by Wall St. Rank hold CLB as of Q2 2019.

SeaCrest Wealth Management reported no remaining Core Laboratories position as of Q2 2019 after selling out during the quarter.
SeaCrest Wealth Management sold 233 Core Laboratories shares in Q2 2019, an estimated $16K.
SeaCrest Wealth Management first reported a position in Core Laboratories in Q4 2017 and held it in 6 quarters.
SeaCrest Wealth Management's Core Laboratories position peaked at $53K in Q2 2018.
304 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2019.

Based on SeaCrest Wealth Management's 13F filing for Q2 2019, filed 19 Jul 2019.